Lymphoma

Pages Tagged with "Lymphoma"

Groundbreaking new therapies provide hope to blood cancer patients
For two groups of patients — older people diagnosed with acute myeloid leukemia (AML) and patients whose aggressive B cell lymphoma did not respond to treatment or had relapsed — the prognosis...
5 Facts About Skin Cancer With Christiane Querfeld, M.D., Ph.D.
Christiane Querfeld, M.D., Ph.D.Skin cancer is the most commonly diagnosed malignancy. Most forms are not life-threatening, except for the rarest form, melanoma. However, even this most aggressive...
City of Hope doctors present innovative therapies to better treat blood cancers at American Society of Hematology virtual conference
CONTACT Letisia Marquez 626-476-7593 lemarquez@coh.org   Advances in providing stem cell transplants to older adults with cancer, novel CAR T cell therapies and other immunotherapies discussed   DUARTE, Calif. —...
City of Hope researcher receives Defense Department Idea Award to study Epstein-Barr virus-related cancers
The Epstein-Barr virus (EBV) is best known for causing mononucleosis, or “mono,” but it is also linked to several types of cancer, including lymphomas and carcinomas. With more than 90%...
Defense Department funds Epstein-Barr virus studies
The Epstein-Barr virus (EBV) is best known for causing mononucleosis, or “mono,” but it is also linked to several types of cancer, including lymphomas and carcinomas. With more than 90%...
New Immunotherapy Research Presented at ASH
City of Hope physicians and researchers at the American Society of Hematology (ASH) meeting in Orlando, Florida, from Dec. 7 to 10 presented research on novel chimeric antigen receptor (CAR)...
Special coronavirus concerns for bone marrow transplant patients
Nicole A. Karras, M.D. While all of us live in the shadow of COVID-19, few are as vulnerable to this virus as bone marrow transplant (BMT) patients. How is City...
City of Hope signs licensing agreement with Scopus BioPharma Inc. to develop novel, targeted immuno-oncology gene therapy
CONTACT Letisia Marquez 626-476-7593 lemarquez@coh.org   A phase 1 clinical trial using the STAT 3 inhibitor is expected to commence at City of Hope later this year   DUARTE, Calif...
COVID-19 concerns delay patient's diagnosis, treatment
The fear of contracting COVID-19 over the last year has caused many people to delay doctor visits. But when your body shows a marked change, overcoming those fears just might...
Scientist working on novel, DNA-based approach to COVID-19 vaccine
Larry W. Kwak, M.D., Ph.D. As tens of thousands of new COVID-19 cases crop up each day worldwide and measures to slow its spread disrupt everyday life, the hopes of...